2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $639M | $1.1B | $1.6B | $1.8B | $664M |
Cost of Revenue | $115M | $235M | $364M | $758M | $0 |
Gross Profit | $524M | $846M | $1.3B | $1.1B | $664M |
Gross Profit % | 82% | 78% | 78% | 59% | 100% |
R&D Expenses | -$2.7 | $1.2 | $0.054 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$405M | $1.5B | $92M | $696M | $0 |
Dep. & Amort. | $221M | -$717M | $981M | $0 | -$217M |
Def. Tax | $0 | $0 | $0 | $0 | $0 |
Stock Comp. | $0 | $0 | $0 | $0 | $0 |
Chg. in WC | $478M | -$363M | $323M | -$88M | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $191M | $377M | $251M | $231M | $278M |
ST Investments | $0 | $0 | $0 | $0 | -$3M |
Cash & ST Inv. | $191M | $377M | $251M | $231M | $278M |
Receivables | $245M | $720M | $439M | $536M | $0 |
Inventory | $0 | $0 | $0 | $0 | $0 |
FSK reduced non-accrual investments by 58% in 2024, achieving 3.7% on a cost basis and 2.2% on a fair value basis, and plans to maintain strong credit quality in 2025.
The company deployed $4.7 billion in capital during 2024 and expects increased M&A activity in 2025, supported by significant available liquidity.
FSK achieved its 2024 distribution goal of $2.9 per share and expects to provide shareholders with $2.8 per share in total distributions for 2025, supported by spillover income.
The investment portfolio had a fair value of $13.5 billion as of December 31, 2024, with a focus on senior secured investments (73% of the portfolio) and a weighted average yield of 11%.
Forward guidance for Q1 2025 includes GAAP net investment income of approximately $0.66 per share and adjusted net investment income of $0.64 per share, with total distributions for the year expected to remain at least $2.8 per share.